{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:58:09Z","timestamp":1790690289765,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1260,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ajpath.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T20:59:32Z","timestamp":1463173172000},"page":"1775-1785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines"],"prefix":"10.1016","volume":"186","author":[{"given":"Laetitia","family":"Andrique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Poglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Prochazkova-Carlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall Edward","family":"Kadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamina","family":"Idrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Merlio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2016.03.012_bib1","first-page":"16","article-title":"Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis","volume":"107","author":"Rook","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"279ra239","DOI":"10.1126\/scitranslmed.3010302","article-title":"Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells","volume":"7","author":"Watanabe","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.03.012_bib4","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653.012k23_3653_3661","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"117ra117","DOI":"10.1126\/scitranslmed.3003008","article-title":"Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients","volume":"4","author":"Clark","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2016.03.012_bib6","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.V96.9.2987","article-title":"Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma","volume":"96","author":"Delfau-Larue","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02631086","article-title":"Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides","volume":"28A","author":"Kaltoft","year":"1992","journal-title":"In\u00a0Vitro Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcb.240630503","article-title":"T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL)","volume":"24","author":"Bunn","year":"1996","journal-title":"J Cell Biochem Suppl"},{"key":"10.1016\/j.ajpath.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.2910490218","article-title":"Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor","volume":"49","author":"Starkebaum","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1073\/pnas.91.13.6002","article-title":"Loss of receptors for transforming growth factor beta in human T-cell malignancies","volume":"91","author":"Kadin","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2016.03.012_bib11","first-page":"1214","article-title":"A CD30-positive T cell line\u00a0established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease","volume":"8","author":"del Mistro","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2016.03.012_bib12","first-page":"142","article-title":"The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines","volume":"10","author":"Dirks","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/sj.leu.2403465","article-title":"Malignant hematopoietic cell lines: in\u00a0vitro models for the study of anaplastic large-cell lymphoma","volume":"18","author":"Drexler","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2013-05-500686","article-title":"Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma","volume":"123","author":"Chevret","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/annonc\/mdn056","article-title":"Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model","volume":"19","author":"Tun-Kyi","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib16","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.0900699","article-title":"Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD\/Shi-scid, IL-2R gamma(null) mice in\u00a0vivo","volume":"183","author":"Ito","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1158\/1078-0432.CCR-07-1324","article-title":"Defucosylated anti CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive\/refractory Mycosis fungoides and Sezary syndrome","volume":"13","author":"Yano","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2016.03.012_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2004.00201.x","article-title":"Establishment of a mouse xenograft model for mycosis fungoides","volume":"13","author":"Thaler","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1600-0625.2010.01138.x","article-title":"A novel xenograft model of cutaneous T-cell lymphoma","volume":"19","author":"Krejsgaard","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-9966-29-11","article-title":"A mouse model for the Sezary syndrome","volume":"29","author":"Doebbeling","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2016.03.012_bib21","doi-asserted-by":"crossref","first-page":"e44455","DOI":"10.1371\/journal.pone.0044455","article-title":"Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2016.03.012_bib22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1600-0625.2012.01556.x","article-title":"A novel mouse model for Sezary syndrome using xenotransplantation of Sezary cells into immunodeficient RAG2(-\/-) gammac(-\/-) mice","volume":"21","author":"van der Fits","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0190-9622(96)80062-4","article-title":"Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients","volume":"34","author":"Zackheim","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/jid.2014.364","article-title":"c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death","volume":"135","author":"Wu","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.0022-202x.2001.01476.x","article-title":"Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas","volume":"117","author":"Beylot-Barry","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib27","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/1097-0142(19800401)45:7<1683::AID-CNCR2820450727>3.0.CO;2-C","article-title":"Hepatic involvement in the cutaneous T-cell lymphomas: results of percutaneous biopsy and peritoneoscopy","volume":"45","author":"Huberman","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2016.03.012_bib28","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.4049\/jimmunol.176.4.2053","article-title":"Experimental models to study development and function of the human immune system in\u00a0vivo","volume":"176","author":"Legrand","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2015-02-628149","article-title":"Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma","volume":"126","author":"Jain","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.03.012_bib30","doi-asserted-by":"crossref","first-page":"e53767","DOI":"10.1371\/journal.pone.0053767","article-title":"t(8;9)(p22;p24)\/PCM1\u2013JAK2 activates SOCS2 and SOCS3 via STAT5","volume":"8","author":"Ehrentraut","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2016.03.012_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/jid.2011.284","article-title":"A humanized stromal bed is required for engraftment of isolated human primary squamous cell carcinoma cells in immunocompromised mice","volume":"132","author":"Patel","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.03.012_bib32","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1158\/0008-5472.CAN-14-1456","article-title":"IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma","volume":"74","author":"Marie-Cardine","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2016.03.012_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016300815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016300815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:08:40Z","timestamp":1576238920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944016300815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0002944016300815"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.03.012","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}